Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q74787561)
Watch
English
Treatment of osteoporosis with bisphosphonates
scientific article published on 01 June 1998
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9669147
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9669147%20AND%20SRC:MED&resulttype=core&format=json
retrieved
13 November 2019
review article
1 reference
stated in
Europe PubMed Central
title
Treatment of osteoporosis with bisphosphonates
(English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9669147
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9669147%20AND%20SRC:MED&resulttype=core&format=json
retrieved
13 November 2019
author name string
N B Watts
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9669147
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9669147%20AND%20SRC:MED&resulttype=core&format=json
retrieved
13 November 2019
publication date
1 June 1998
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9669147
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9669147%20AND%20SRC:MED&resulttype=core&format=json
retrieved
13 November 2019
published in
Endocrinology and Metabolism Clinics of North America
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9669147
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9669147%20AND%20SRC:MED&resulttype=core&format=json
retrieved
13 November 2019
volume
27
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9669147
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9669147%20AND%20SRC:MED&resulttype=core&format=json
retrieved
13 November 2019
issue
2
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9669147
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9669147%20AND%20SRC:MED&resulttype=core&format=json
retrieved
13 November 2019
page(s)
419-439
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9669147
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9669147%20AND%20SRC:MED&resulttype=core&format=json
retrieved
13 November 2019
cites work
The acute-phase response after bisphosphonate administration
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970014-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Mineralisation defects with pamidronate therapy for Paget's disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970014-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Influence of disodium etidronate on clinical and laboratory manifestations of Paget's disease of bone (osteitis deformans)
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970014-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Preliminary observations of a form of coherence therapy for osteoporosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970014-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Antiresorptive effect of a single infusion of microgram quantities of zoledronate in Paget's disease of bone
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970014-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Evaluation and management of heterotopic ossification in patients with spinal cord injury
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970014-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Myositis ossificans progressiva: a 10-year follow-up on a patient treated with etidronate disodium
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970014-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Diphosphonates in the treatment of myositis ossificans.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970014-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Efficacy of Pamidronate in Reducing Skeletal Events in Patients with Advanced Multiple Myeloma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970014-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pharmacokinetics of pamidronate disodium in patients with cancer with normal or impaired renal function
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970014-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970014-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Nonclinical model for assessing gastric effects of bisphosphonates
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970014-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Renal failure associated with intravenous diphosphonates
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970014-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Focal osteomalacia due to low-dose diphosphonate therapy in Paget's disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970014-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effects of tiludronate on bone loss in paraplegic patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970014-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cortical osteoclasts are less sensitive to etidronate than trabecular osteoclasts
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970014-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Tiludronate: development as an osteoporosis therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970014-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Short-term effects of pamidronate in patients with Gaucher's disease and severe skeletal involvement
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970014-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Delay in progression of bone metastases in breast cancer patients treated with intravenous pamidronate: results from a multinational randomized controlled trial. The Aredia Multinational Cooperative Group.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970014-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pamidronate and uveitis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970014-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Esophagitis associated with the use of alendronate
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970014-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Serum kinetics, bioavailability and bone scanning of 99mTc-labelled sodium olpadronate in patients with different rates of bone turnover
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970014-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Bisphosphonate risedronate prevents bone loss in women with artificial menopause due to chemotherapy of breast cancer: a double-blind, placebo-controlled study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970014-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The management of Paget's disease of bone
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970014-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Retrobulbar optic neuritis after pamidronate administration in a patient with a history of cutaneous porphyria
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970014-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Oral alendronate induces progressive increases in bone mass of the spine, hip, and total body over 3 years in postmenopausal women with osteoporosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970014-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Severe reaction to diphosphonate: implications for treatment of Paget's disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970014-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Spontaneous Fractures in a Patient Treated with Low Doses of Etidronic Acid (Disodium Etidronate)
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970014-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cyclical intravenous clodronate in postmenopausal osteoporosis: results of a long-term clinical trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970014-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cyclical clodronate is effective in preventing postmenopausal bone loss: A comparative study with transcutaneous hormone replacement therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970014-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pamidronate. A review of its pharmacological properties and therapeutic efficacy in resorptive bone disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970014-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Diphosphonates: History and mechanisms of action
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970014-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Bisphosphonates: mechanisms of action and clinical use in osteoporosis--an update
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970014-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Diphosphonates inhibit hydroxyapatite dissolution in vitro and bone resorption in tissue culture and in vivo
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970014-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effect of pyrophosphate on hydroxyapatite and its implications in calcium homeostasis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970014-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Bisphosphonates: preclinical aspects and use in osteoporosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970014-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Diphosphonates inhibit formation of calcium phosphate crystals in vitro and pathological calcification in vivo.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970014-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Intravenous pamidronate in the treatment of osteoporosis associated with corticosteroid dependent lung disease: an open pilot study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970014-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Side-effects of pamidronate
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970014-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Studies of the oral bioavailability of alendronate.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970014-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Uveitis associated with pamidronate
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970014-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Continuous and cyclical clodronate therapies and bone density in postmenopausal bone loss
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970014-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Lower extremity stress fractures during intermittent cyclical etidronate treatment for osteoporosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970014-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Treatment with etidronate for men with idiopathic osteoporosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970014-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Four-year study of intermittent cyclic etidronate treatment of postmenopausal osteoporosis: three years of blinded therapy followed by one year of open therapy.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970014-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Drugs recently released in Belgium. Epanolol--Clodronate dinatrium
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970014-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Etidronate disodium in postmenopausal osteoporosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970014-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Bisphosphonate effects and the bone remodeling transient.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970014-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Short-term intravenous bisphosphonates in prevention of postmenopausal bone loss
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970014-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The prevention of early postmenopausal bone loss by cyclical etidronate therapy: a 2-year, double-blind, placebo-controlled study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970014-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Efficacy of pamidronate in reducing skeletal complications in patients with breast cancer and lytic bone metastases. Protocol 19 Aredia Breast Cancer Study Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970014-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Symptomatic hypocalcaemia after treatment with high-dose aminohydroxypropylidene diphosphonate
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970014-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Clodronate decreases the frequency of skeletal metastases in women with breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970014-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Clodronate and osteoporosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970014-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prevention of nonvertebral fractures by alendronate. A meta-analysis. Alendronate Osteoporosis Treatment Study Groups.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970014-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Retention of etidronate in human, dog, and rat
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970014-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The effects of etidronate disodium on progressive hearing loss from otosclerosis.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970014-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Diminished effect of etidronate in vitamin D deficient osteopenic postmenopausal women
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970014-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Hypercalcemia of malignancy in the palliative care patient: a treatment strategy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970014-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Role of oral pamidronate in preventing bone loss in postmenopausal women
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970014-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effect of EHDP on fracture healing in dogs
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970014-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970014-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Long-term effects of intravenous pamidronate in fibrous dysplasia of bone
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970014-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Acute effects of pamidronate administration on serum levels of interleukin-6 in advanced solid tumour patients with bone metastases and their possible implications in the immunotherapy of cancer with interleukin-2
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970014-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Bisphosphonates can reduce osteoclastic bone resorption by two different mechanisms
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970014-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pamidronate disodium and possible ocular adverse drug reactions
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970014-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cyclic therapy of osteoporosis with neutral phosphate and brief, high-dose pulses of etidronate
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970014-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The effect of pamidronate on lumbar spine bone density and pain in osteoporosis secondary to systemic mastocytosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970014-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Severe hypocalcaemia after treatment with oral clodronate and aminoglycoside
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970014-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Ueber die Einwirkung des Chloracetyls auf phosphorige Säure
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970014-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prevention of early postmenopausal bone loss with cyclical etidronate therapy (a double-blind, placebo-controlled study and 1-year follow-up)
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970014-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cyclical etidronate in the treatment of postmenopausal osteoporosis: efficacy and safety after seven years of treatment.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970014-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A new bisphosphonate, BM 21.0955, prevents bone loss associated with cessation of ovarian function in experimental dogs
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970014-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Diphosphonates and inhibition of bone mineralization
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970014-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Acute renal failure associated with the administration of parenteral etidronate
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970014-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Comparison of changes in bone mineral in idiopathic and secondary osteoporosis following therapy with cyclical disodium etidronate and high dose calcium supplementation.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970014-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effects of prolonged bisphosphonate therapy and its discontinuation on bone mineral density in post-menopausal osteoporosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970014-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Erythroderma after clodronate treatment
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970014-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Intermittent treatment with intravenous 4-amino-1-hydroxybutylidene-1,1-bisphosphonate (AHBuBP) in the therapy of postmenopausal osteoporosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970014-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Administration of the bisphosphonate ibandronate (BM 21.0955) by intravenous bolus injection
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970014-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cyclical pamidronate infusions in postmenopausal osteoporosis.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970014-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effect of alendronate on fracture healing and bone remodeling in dogs
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970014-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Clodronate. A review of its pharmacological properties and therapeutic efficacy in resorptive bone disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970014-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The effect on bone mass and bone markers of different doses of ibandronate: a new bisphosphonate for prevention and treatment of postmenopausal osteoporosis: a 1-year, randomized, double-blind, placebo-controlled dose-finding study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970014-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Ototoxicity associated with intravenous bisphosphonate administration.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970014-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effects of oral clodronate on bone mineral density in patients with relapsing breast cancer.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970014-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Bisphosphonates: mechanisms of action
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970014-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Inhibitory effects of bisphosphonates on growth of amoebae of the cellular slime mold Dictyostelium discoideum
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970014-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Bisphosphonate-induced bronchoconstriction in aspirin-sensitive asthma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970014-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Therapy with parenteral pamidronate prevents thyroid hormone-induced bone turnover in humans
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970014-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Comparative prospective, double-blind, multicenter study of the efficacy of tiludronate and etidronate in the treatment of Paget's disease of bone
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970014-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Long-lasting dermatological lesions after tiludronate therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970014-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prevention of hypercalciuria and stone-forming propensity during prolonged bedrest by alendronate
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970014-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Bisphosphonates act on rat bone resorption through the mediation of osteoblasts
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970014-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Human pharmacokinetics of tiludronate
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970014-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Bisphosphonate action. Alendronate localization in rat bone and effects on osteoclast ultrastructure
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970014-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Bisphosphonates: a new treatment for diabetic Charcot neuroarthropathy?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970014-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Clinical and biochemical effects of EHDP in Paget's disease of bone: patterns of response to initial treatment and to long-term therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970014-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The effects of etidronate on trabecular bone remodeling in postmenopausal spinal osteoporosis: a randomized study comparing intermittent treatment and an ADFR regime
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970014-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Iritis following intravenous pamidronate
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970014-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Changes in bone histomorphometry after long-term treatment with intermittent, cyclic etidronate for postmenopausal osteoporosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970014-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women with postmenopausal osteoporosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970014-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Analgesic effect of bisphosphonates on bone pain in breast cancer patients: a review article
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970014-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effect of three years of oral alendronate treatment in postmenopausal women with osteoporosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970014-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Extracellular and intracellular action of clodronate in osteolytic bone diseases? A hypothesis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970014-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Sustained response to intravenous alendronate in postmenopausal osteoporosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970014-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Bisphosphonates induce osteoblasts to secrete an inhibitor of osteoclast-mediated resorption
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970014-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Intermittent cyclical etidronate treatment of postmenopausal osteoporosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970014-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Combined therapy with estrogen and etidronate has an additive effect on bone mineral density in the hip and vertebrae: four-year randomized study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970014-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S0889-8529(05)70014-1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9669147
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9669147%20AND%20SRC:MED&resulttype=core&format=json
retrieved
13 November 2019
PubMed publication ID
9669147
1 reference
stated in
Europe PubMed Central
PubMed publication ID
9669147
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9669147%20AND%20SRC:MED&resulttype=core&format=json
retrieved
13 November 2019
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit